Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...

"This will also allow the development of novel vaccines with controlled antigenicity and pathogenicity," explains senior author Takeshi Kobayashi. This system fills a critical gap in human norovirus ...

Researchers have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines. Norovirus is the ...

New outbreaks of gastrointestinal illnesses on cruise ships have sickened about 150 people, adding to the growing toll of such cases in 2025 ahead of peak cruise season, according to the Centers for ...

Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...

A new study published in Water & Ecology reveals that common waterborne amoebae can ingest and protect human viruses, extending their environmental persistence. Human norovirus (HNoV) and human ...

Cases are more common in the winter as people spend more time indoors and in settings like schools, long-term care facilities and daycares.

Norovirus cases are rising in 2025, prompting questions about vaccine availability. Here’s what experts say about symptoms, ...

Norovirus is most common in certain settings, and it can spread through seafood, according to the Centers for Disease Control and Prevention.